Survey reveals skyrocketing interest in marijuana and

New Post Public Reply Private Reply Replies (1) Message Board
Lee Adams Lee Adams #46
454
Survey reveals skyrocketing interest in marijuana and cannabinoids for pain. These Companies are aggressively building for this consumer confidence

August 27, 2019 -- InvestorsHub NewsWire -- via Corporate Ads -- The Target Group (OTCQB: CBDY)

https://ih.advfn.com/stock-market/USOTC/targe...-marijuana

Positioned to Serve the New Legal Cannabis Marketplace with High Quality Supply Sources, an innovative herbal vaporizer system and its Own Established Growth Facility.

Based in Ontario, Canada is a progressive, diversified, and vertically integrated cannabis investment company. CBDY has completed an impressive growth facility and is expanding operations to build an international network of manufacturing, distribution, production, and sales operations. This company is creating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability.

Target Group, with the very appropriate trading symbol of CBDY, is positioned with the assets, professional management experience and specific industry expertise to address the needs of the new cannabis related businesses emerging today.

In May of 2019 CBDY's wholly owned subsidiary, Canary Rx Inc. completed the build-out of a new 44,000 sq. ft. cannabis production facility in Norfolk County, Ontario. The production area is equipped with sophisticated environmental control technology, custom-built to regulate eight 2,200 sq. ft. flower rooms as well as vegetative, breeding, testing, and curing spaces. Once fully operational, this facility expected to produce 3,600kg of premium, organic cannabis per year.

Also in Target Group's Portfolio[KM1] is CannaKorp, Inc., which has developed the world's first single-use pod, herbal vaporizer system, delivering unprecedented quality, convenience and consistency. The complete system includes the ground breaking vaporizer device, WISP™, single-use, precisely measured pods containing pre-ground, lab-tested botanical herbs called WISP Pods™; and a proprietary pod-filling process. CannaKorp, Inc. was founded on care and commitment to patients and consumers, and is guided by a philosophy of social and environmental responsibility.

In summary, Target Group (CBDY) is at a pivotal moment where an entire industry is just coming into play and this company is ready to participate in a very significant role. Learn more via the company websites:Target Group, Inc. http://www.targetgroupinc.ca and Canary Rx Inc. http://www.canaryrx.com

Canopy Growth Corp. (CGC)The first Canadian marijuana company, Canopy Growth Corp. is the world's largest publicly traded weed company. The company owns and operates many brands, producing and marketing both medical and recreational strains. Tweed is one of the company's most popular brands, thanks to an association with rapper Snoop Dogg. For its 2019 fiscal year, it reported revenue of CAD 77.9 million or nearly $60 million. https://www.canopygrowth.com/ ;

Acacia Diversified Holdings (OTCQB: ACCA)Positioned for a Key Role as a Trusted Supplier of Optimized Medical Cannabis SolutionsThe ACCA growth facilities, located in both Florida and Tennessee, are situated indoors which offer distinct advantages, particularly a much more controlled environment. In February 2019 ACCA announced that its wholly-owned subsidiary Eufloria Medical of Tennessee, had entered into a Hemp Research Partnership with Tennessee State University (TSU). EufloriaMedical will produce the cannabis material for this important study. In May, Eufloria also reported that it has completed phase one of the construction work for 16,000 Sq./ft of the indoor space at its Tennessee farm. Phase two is underway now with specialized equipment being installed. http://www.acaciadiversifiedholdings.com

Aurora Cannabis Inc. (ACB)Another big Canadian pot company, Aurora Cannabis became even bigger in March by acquiring rival MedReleaf in a $250 million all-stock deal that was touted as the world's largest marijuana deal to date.Consolidating operations will help the new entity cut costs and gain efficiency. According to a press release, Aurora and MedReleaf together expect to produce over 570,000 kilograms per year of cannabis through nine facilities in Canada and two in Denmark. Aurora debuted on the Canadian venture stock exchange (TSX) in October 2016 and trades in the U.S. on the NYSE. https://www.auroramj.com/

Cronos Group Inc. (CRON)Nasdaq's first pot stock, Cronos Group is a Toronto-based cultivator of medical marijuana.In addition to Canada, Cronos serves international markets, shipping its products to Germany, building a facility in Israel, and starting a joint venture in Australia. Cronos Group does not have a presence in the U.S. due to the uncertainty in regulations.As of its 2018 fiscal year, the company generated $7.3 million in revenue. https://thecronosgroup.com/ ;

DISCLAIMER: CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. CA is NOT affiliated in any manner with any company mentioned herein. CA is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. CA's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CA has been compensated $1,000.00 for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. Disclaimer/Safe Harbor:This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. [KM1]SOURCE: Corporate AdsTarget Group Inc. (USOTC:CBDY)Historical Stock Chart1 Year : From Aug 2018 to Aug 2019

Target Group Inc. (CBDY) Stock Research Links

CBDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 501

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 130

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 564

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 707

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 299

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 112

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 496

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading